|
Volumn 1022, Issue , 2004, Pages 263-270
|
Clinical role of circulating Epstein-Barr virus DNA as a tumor marker in lymphoepithelioma-like carcinoma of the lung
|
Author keywords
Epstein Barr virus (EBV) DNA; Longitudinal profile; Lung lymphoepithelioma like carcinoma (LELC); Quantitative polymerase chain reaction (PCR); Tumor marker
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
VIRUS DNA;
ADULT;
BLOOD SAMPLING;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER SURGERY;
CANCER SURVIVAL;
CHINESE;
CIRCULATION;
CLINICAL ARTICLE;
CONCENTRATION (PARAMETERS);
CONFERENCE PAPER;
CONTROLLED STUDY;
CONVALESCENCE;
CORRELATION ANALYSIS;
DISEASE DURATION;
EPSTEIN BARR VIRUS;
FEMALE;
HUMAN;
HUMAN TISSUE;
LUNG CARCINOMA;
LYMPHOEPITHELIOMA;
MALE;
MONITORING;
POLYMERASE CHAIN REACTION;
PROSPECTIVE STUDY;
QUANTITATIVE ANALYSIS;
SERUM;
STATISTICAL SIGNIFICANCE;
SURGICAL TRAINING;
TREATMENT OUTCOME;
DNA VIRUSES;
HUMAN HERPESVIRUS 4;
|
EID: 3242684086
PISSN: 00778923
EISSN: None
Source Type: Book Series
DOI: 10.1196/annals.1318.041 Document Type: Conference Paper |
Times cited : (43)
|
References (7)
|